Pliant Therapeutics (PLRX) Revenue (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly Revenue of $248000.0 for Q2 2023, down 95.03% year-over-year from $5.0 million in Q2 2022, and down 81.38% quarter-over-quarter from $1.3 million in Q1 2023.
Pliant Therapeutics (PLRX) Revenue (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Revenue for 4 consecutive years, with $248000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Revenue fell 95.03% year-over-year to $248000.0; the TTM figure through Mar 2024 stood at $248000.0 (down 97.46% YoY), while the FY2023 annual figure was $1.6 million, down 83.69% from the prior year.
- Revenue slipped to $248000.0 in Q2 2023 per PLRX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Revenue topped out at $28.9 million in Q1 2020 and bottomed at $248000.0 in Q2 2023.
- Historically, Revenue has averaged $4.3 million across 4 years, with a median of $2.0 million in 2021.
- Annual changes were most pronounced in 2022 — Revenue surged 178.87% — and 2023, when it plunged 95.03%.
- Pliant Therapeutics' Revenue stood at $4.4 million in 2020, then slumped by 54.74% to $2.0 million in 2021, then declined by 1.7% to $2.0 million in 2022, then plunged by 87.38% to $248000.0 in 2023.
- Business Quant data shows PLRX's Revenue at $248000.0 in Q2 2023, $1.3 million in Q1 2023, and $2.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 248,000.00 |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 4.99 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 1.79 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 4.42 Mn |
| Sep 30, 2020 | 4.81 Mn |
| Jun 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 28.94 Mn |